Human CellExp™ TNFSF11 / RANKL / CD254, Human Recombinant

(No reviews yet) Write a Review
SKU:
26-P1206
Availability:
Usually Shipped in 5 Working Days
Storage Temperature:
-20°C
Shipping Conditions:
Gel Pack
Shelf Life:
12 months
£153.94 - £472.14
Frequently bought together:

Description

Biomolecule/Target: TNFSF11

Synonyms: RANKL, CD254, TRANCE, OPGL, ODF

Alternates names: RANKL, CD254, TRANCE, OPGL, ODF

Taglines: Tumor necrosis factor ligand superfamily member 11 stimulates osteoclast formation.

Taglines: USA

Country of Animal Origin: USA

NCBI Gene ID #.: 8600

NCBI Gene Symbol: TNFSF11

Gene Source: Human

Accession #: O14788

Recombinant: Yes

Source: HEK293 cells

Purity by SDS-PAGE #: > 95%

Assay: SDS-PAGE

Purity: N/A

Assay #2: N/A

Endotoxin Level: < 1.0 EU per/μg

Activity (Specifications/test method): Measured by its binding ability in a functional ELISA.

Biological activity: Immobilized Human TNFRSF11A at 5 μg/mL (100 μL/well) can bind Human TNFSF11, His Tag with a linear range of 0.2-6 ng/mL

Results: N/A

Binding Capacity: Immobilized Human TNFRSF11A at 5 μg/mL (100 μL/well) can bind Human TNFSF11, His Tag with a linear range of 0.2-6 ng/mL

Unit Definition: N/A

Molecular Weight: 23.1 kDa

Concentration: N/A

Appearance: Lyophilized

Physical form description: Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Generally Mannitol or Trehalose is added as a protectant before lyophilization.

Reconstitution Instructions: Reconstitute in sterile deionized water to the desired protein concentration.

Background Information: Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL, through its ability to stimulate osteoclast formation and activity, is a critical mediator of bone resorption and overall bone density. Some findings also suggestion some cancer cells, particularly prostate cancer cells, can activate an increase in bone remodeling and ultimately increase overall bone production.[17] This increase in bone remodeling and bone production increases the overall growth of bone metastasizes.

Amino acid sequence: N/A

Handling: Centrifuge the vial prior to opening.

Usage: For Research Use Only! Not to be used in humans

View AllClose